Q1 performance exceeded expectations

Gelonghui, April 25 | Align Technology (ALGN.US), a dental medical device company, rose 4.85% to US$329 before the market opened. According to the news, the company\’s revenue for the quarter ended March 31 increased to US$997.4 million from US$943.1 million in the same period last year; non-GAAP earnings per diluted share were US$2.14, higher than analysts\’ expectations of US$1.97. For the second quarter, the company expects revenue of $1.03 billion to $1.05 billion.